A detailed history of Xponance, Inc. transactions in Opko Health, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 20,611 shares of OPK stock, worth $33,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,611
Previous 20,842 1.11%
Holding current value
$33,183
Previous $26,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.21 - $1.68 $279 - $388
-231 Reduced 1.11%
20,611 $30,000
Q2 2024

Aug 14, 2024

SELL
$1.21 - $1.42 $3,388 - $3,976
-2,800 Reduced 11.84%
20,842 $26,000
Q1 2024

May 13, 2024

SELL
$0.87 - $1.57 $486 - $877
-559 Reduced 2.31%
23,642 $28,000
Q4 2023

Jan 31, 2024

BUY
$1.23 - $1.63 $386 - $511
314 Added 1.31%
24,201 $36,000
Q3 2023

Oct 23, 2023

BUY
$1.5 - $2.17 $1,318 - $1,907
879 Added 3.82%
23,887 $38,000
Q4 2022

Jan 23, 2023

BUY
$1.05 - $2.01 $550 - $1,053
524 Added 2.33%
23,008 $0
Q3 2022

Oct 24, 2022

BUY
$1.81 - $2.81 $1,317 - $2,045
728 Added 3.35%
22,484 $42,000
Q2 2022

Aug 02, 2022

BUY
$2.33 - $3.61 $4,690 - $7,266
2,013 Added 10.2%
21,756 $55,000
Q1 2022

Apr 20, 2022

BUY
$2.87 - $4.93 $1,110 - $1,907
387 Added 2.0%
19,743 $68,000
Q4 2021

Jan 31, 2022

BUY
$3.52 - $5.15 $2,016 - $2,950
573 Added 3.05%
19,356 $93,000
Q3 2021

Nov 05, 2021

SELL
$3.44 - $4.24 $9,425 - $11,617
-2,740 Reduced 12.73%
18,783 $69,000
Q2 2021

Aug 12, 2021

BUY
$3.33 - $4.55 $71,671 - $97,929
21,523 New
21,523 $87,000
Q1 2021

May 10, 2021

SELL
$4.19 - $5.99 $47,074 - $67,297
-11,235 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$3.27 - $4.87 $209 - $311
-64 Reduced 0.57%
11,235 $44,000
Q3 2020

Oct 26, 2020

SELL
$2.99 - $5.96 $21,273 - $42,405
-7,115 Reduced 38.64%
11,299 $42,000
Q2 2020

Aug 14, 2020

BUY
$1.15 - $3.41 $21,176 - $62,791
18,414 New
18,414 $63,000

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.24B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.